DNA test provider Prenetics jumps after lifting annual forecast
Shares of DNA test provider Prenetics Global PRE.O rise 16.25% at $10.30 in early trading
Co increases FY2025 revenue outlook to $85 mln to $100 mln from previous forecast of $80 mln to $100 mln; aims for break-even in Q1 2026
Prenetics reports almost 600% quarterly revenue jump of $17.7 million compared to previous year, but below expectations of $21.70 million - data compiled by LSEG
As of last close, PRE up 52.76% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Palantir Q1 2026 Earnings Preview — Is PLTR a Buy at $144?

ORCL Stock: Why Oracle May Be the Beaten-Down Tech Giant Ready for a Comeback

Nvidia Makes First Bet on Legal AI, Invests $50 Million in Legora

Is Lululemon Stock a Buy or a Risky Bet Amidst Financial Pressure and Management Changes?

VOO Stock Price: Is the S&P 500 ETF Still the Smarter Buy vs QQQ?

Tradingkey






